ProShare Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.9K | Buy |
31,368
+5,953
| +23% | +$12.3K | ﹤0.01% | 1958 |
|
|
2025
Q1 | $55.9K | Sell |
25,415
-7,648
| -23% | -$16.8K | ﹤0.01% | 1939 |
|
|
2024
Q4 | $50.6K | Buy |
33,063
+10,880
| +49% | +$16.6K | ﹤0.01% | 2174 |
|
|
2024
Q3 | $44.1K | Buy |
22,183
+8,314
| +60% | +$16.5K | ﹤0.01% | 1990 |
|
|
2024
Q2 | $48.5K | Sell |
13,869
-4,735
| -25% | -$16.6K | ﹤0.01% | 1753 |
|
|
2024
Q1 | $51.5K | Buy |
18,604
+1,466
| +9% | +$4.06K | ﹤0.01% | 1900 |
|
|
2023
Q4 | $29.1K | Buy |
17,138
+3,685
| +27% | +$6.27K | ﹤0.01% | 1901 |
|
|
2023
Q3 | $13.9K | Sell |
13,453
-14
| -0.1% | -$14 | ﹤0.01% | 1799 |
|
|
2023
Q2 | $15.6K | Buy |
13,467
+1,355
| +11% | +$1.57K | ﹤0.01% | 1842 |
|
|
2023
Q1 | $18.3K | Sell |
12,112
-1,130
| -9% | -$1.71K | ﹤0.01% | 1739 |
|
|
2022
Q4 | $33.1K | Buy |
13,242
+1,898
| +17% | +$4.75K | ﹤0.01% | 1776 |
|
|
2022
Q3 | $48K | Sell |
11,344
-218
| -2% | -$922 | ﹤0.01% | 1663 |
|
|
2022
Q2 | $32K | Sell |
11,562
-5,762
| -33% | -$15.9K | ﹤0.01% | 1746 |
|
|
2022
Q1 | $99K | Sell |
17,324
-2,822
| -14% | -$16.1K | ﹤0.01% | 2035 |
|
|
2021
Q4 | $184K | Buy |
20,146
+8,308
| +70% | +$75.9K | ﹤0.01% | 2063 |
|
|
2021
Q3 | $127K | Sell |
11,838
-12,130
| -51% | -$130K | ﹤0.01% | 1874 |
|
|
2021
Q2 | $372K | Buy |
23,968
+551
| +2% | +$8.55K | ﹤0.01% | 1742 |
|
|
2021
Q1 | $380K | Buy |
23,417
+4,002
| +21% | +$64.9K | ﹤0.01% | 1643 |
|
|
2020
Q4 | $411K | Buy |
19,415
+8,673
| +81% | +$184K | ﹤0.01% | 1393 |
|
|
2020
Q3 | $159K | Sell |
10,742
-1,168
| -10% | -$17.3K | ﹤0.01% | 1455 |
|
|
2020
Q2 | $175K | Buy |
+11,910
| New | +$175K | ﹤0.01% | 1492 |
|
|
2020
Q1 | – | Sell |
-11,395
| Closed | -$268K | – | 1351 |
|
|
2019
Q4 | $268K | Buy |
+11,395
| New | +$268K | ﹤0.01% | 1410 |
|
|
2018
Q4 | – | Sell |
-8,432
| Closed | -$267K | – | 1630 |
|
|
2018
Q3 | $267K | Buy |
8,432
+28
| +0.3% | +$887 | ﹤0.01% | 1433 |
|
|
2018
Q2 | $326K | Buy |
+8,404
| New | +$326K | ﹤0.01% | 1333 |
|